Co-Diagnostics, Inc. Accounts Receivable
Co-Diagnostics, Inc. (CODX) had Accounts Receivable of $52.06 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $52.06K.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $82.34K.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $190.38K.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $55.91K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2026-06-30 | $52.06K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $82.34K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $190.38K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $55.91K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $210.97K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $136.39K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $132.57K 10-Q · filed 2026-08-13 |
| 2024-09-30 | $178.24K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $551.50K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $434.87K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $303.93K 10-K · filed 2026-03-31 |
| 2023-09-30 | $806.70K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.10M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.70M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $3.45M 10-K · filed 2025-03-27 |
| 2022-09-30 | $7.96M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $12.26M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $21.66M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $20.84M 10-K · filed 2023-03-16 |
| 2021-09-30 | $14.59M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $12.76M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $12.12M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $12.14M 10-K · filed 2022-03-24 |
| 2020-09-30 | $10.64M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $5.35M 10-Q/A · filed 2020-11-03 |
| 2020-03-31 | $1.06M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $131.38K 10-K · filed 2021-03-25 |
| 2019-09-30 | $60.35K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $62.98K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $42.56K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $13.42K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |